Portfolio Holdings Detail for ISIN IE00BF4RFH31
| Stock Name / Fund | iShares MSCI World Small Cap UCITS ETF USD (Acc) |
| Issuer | Blackrock |
| Entity holding fund | iShares III Public Limited Company |
| Entity Type | Umbrella investment company with variable capital and having segregated liability between its funds |
| Entity LEI | 549300PZLRJB7M8H1057 |
| ETF Ticker | WSML(USD) LSE |
| ETF Ticker | WLDS(GBP) LSE |
| ETF Ticker | IUSN(EUR) F |
| ETF Ticker | IUSN.DE(EUR) CXE |
| ETF Ticker | WLDS.LS(GBP) CXE |
| ETF Ticker | WSML.LS(USD) CXE |
| ETF Ticker | WSML.L(GBP) LSE |
| ETF Ticker | WLDS.L(GBP) LSE |
Holdings detail for DNA
| Stock Name | Ginkgo Bioworks Holdings |
| Ticker | DNA(USD) NYSE |
| TYPE | Common Stock |
| Country | USA |
| ISIN | US37611X1000 |
Show aggregate DNA holdings
News associated with DNA
- Ginkgo Bioworks (NYSE:DNA) Price Target Raised to $9.00
- Ginkgo Bioworks (NYSE:DNA – Free Report) had its target price lifted by BTIG Research from $6.00 to $9.00 in a report issued on Monday morning,Benzinga reports. The firm currently has a sell rating on the stock. Separately, Cowen restated a “buy” rating on shares of Ginkgo Bioworks in a research report on Friday, August 8th. […] - 2025-08-26 02:54:46
- Ginkgo Bioworks Holdings, Inc. (NYSE:DNA) Shares Purchased by Exchange Traded Concepts LLC
- Exchange Traded Concepts LLC lifted its holdings in Ginkgo Bioworks Holdings, Inc. (NYSE:DNA – Free Report) by 63.0% in the first quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 311,846 shares of the company’s stock after purchasing an additional 120,572 shares during the quarter. Exchange […] - 2025-06-18 05:18:50
- Squarepoint Ops LLC Sells 60,696 Shares of Ginkgo Bioworks Holdings, Inc. (NYSE:DNA)
- Squarepoint Ops LLC reduced its holdings in shares of Ginkgo Bioworks Holdings, Inc. (NYSE:DNA – Free Report) by 58.8% in the 4th quarter, Holdings Channel.com reports. The fund owned 42,490 shares of the company’s stock after selling 60,696 shares during the period. Squarepoint Ops LLC’s holdings in Ginkgo Bioworks were worth $417,000 as of its […] - 2025-06-06 05:14:56
- Millennium Management LLC Buys 523,571 Shares of Ginkgo Bioworks Holdings, Inc. (NYSE:DNA)
- Millennium Management LLC increased its stake in shares of Ginkgo Bioworks Holdings, Inc. (NYSE:DNA – Free Report) by 357.4% during the 4th quarter, Holdings Channel.com reports. The firm owned 670,065 shares of the company’s stock after acquiring an additional 523,571 shares during the quarter. Millennium Management LLC’s holdings in Ginkgo Bioworks were worth $6,580,000 at […] - 2025-05-28 04:56:51
- Ginkgo Bioworks Holdings, Inc. (NYSE:DNA) Shares Acquired by Bank of America Corp DE
- Bank of America Corp DE grew its position in Ginkgo Bioworks Holdings, Inc. (NYSE:DNA – Free Report) by 780.6% in the fourth quarter, according to the company in its most recent disclosure with the SEC. The firm owned 3,764,455 shares of the company’s stock after acquiring an additional 3,336,964 shares during the period. Bank of […] - 2025-05-16 06:03:08
- BNP Paribas Financial Markets Increases Stake in Ginkgo Bioworks Holdings, Inc. (NYSE:DNA)
- BNP Paribas Financial Markets raised its holdings in shares of Ginkgo Bioworks Holdings, Inc. (NYSE:DNA – Free Report) by 80.6% in the fourth quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The fund owned 285,111 shares of the company’s stock after buying an additional 127,249 shares during […] - 2025-05-16 05:24:57
- Tower Research Capital LLC TRC Has $167,000 Stake in Ginkgo Bioworks Holdings, Inc. (NYSE:DNA)
- Tower Research Capital LLC TRC lessened its holdings in shares of Ginkgo Bioworks Holdings, Inc. (NYSE:DNA – Free Report) by 18.7% during the fourth quarter, HoldingsChannel.com reports. The firm owned 16,972 shares of the company’s stock after selling 3,899 shares during the quarter. Tower Research Capital LLC TRC’s holdings in Ginkgo Bioworks were worth $167,000 […] - 2025-05-07 05:32:53
- Ginkgo Bioworks (NYSE:DNA) versus Palisade Bio (NASDAQ:PALI) Financial Contrast
- Ginkgo Bioworks (NYSE:DNA – Get Free Report) and Palisade Bio (NASDAQ:PALI – Get Free Report) are both small-cap medical companies, but which is the better investment? We will contrast the two businesses based on the strength of their earnings, profitability, valuation, analyst recommendations, risk, institutional ownership and dividends. Analyst Ratings This is a breakdown of […] - 2025-05-07 03:08:50
- Marshall Wace LLP Makes New $665,000 Investment in Ginkgo Bioworks Holdings, Inc. (NYSE:DNA)
- Marshall Wace LLP purchased a new stake in Ginkgo Bioworks Holdings, Inc. (NYSE:DNA – Free Report) in the fourth quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The institutional investor purchased 67,684 shares of the company’s stock, valued at approximately $665,000. Marshall Wace LLP owned approximately 0.12% of Ginkgo […] - 2025-05-02 05:32:47
- SBI Securities Co. Ltd. Purchases Shares of 2,905 Ginkgo Bioworks Holdings, Inc. (NYSE:DNA)
- SBI Securities Co. Ltd. purchased a new stake in Ginkgo Bioworks Holdings, Inc. (NYSE:DNA – Free Report) during the fourth quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The fund purchased 2,905 shares of the company’s stock, valued at approximately $29,000. Other institutional investors have also […] - 2025-03-13 06:02:49
iShares MSCI World Small Cap UCITS ETF USD (Acc) DNA holdings
| Date | Number of DNA Shares Held | Base Market Value of DNA Shares | Local Market Value of DNA Shares | Change in DNA Shares Held | Change in DNA Base Value | Current Price per DNA Share Held | Previous Price per DNA Share Held |
|---|
| 2025-11-27 (Thursday) | 20,230 | USD 184,295 | USD 184,295 | 0 | USD 0 | USD 9.10999 | USD 9.10999 |
| 2025-11-26 (Wednesday) | 20,230 | USD 184,295 | USD 184,295 | -45 | USD 7,700 | USD 9.10999 | USD 8.70999 |
| 2025-11-25 (Tuesday) | 20,275 | USD 176,595 | USD 176,595 | 0 | USD 2,027 | USD 8.70999 | USD 8.61001 |
| 2025-11-24 (Monday) | 20,275 | USD 174,568 | USD 174,568 | 0 | USD 8,921 | USD 8.61001 | USD 8.17001 |
| 2025-11-21 (Friday) | 20,275 | USD 165,647 | USD 165,647 | 0 | USD 7,096 | USD 8.17001 | USD 7.82002 |
| 2025-11-20 (Thursday) | 20,275 | USD 158,551 | USD 158,551 | 135 | USD -756 | USD 7.82002 | USD 7.90998 |
| 2025-11-19 (Wednesday) | 20,140 | USD 159,307 | USD 159,307 | 1,320 | USD 11,946 | USD 7.90998 | USD 7.83002 |
| 2025-11-18 (Tuesday) | 18,820 | USD 147,361 | USD 147,361 | 0 | USD 941 | USD 7.83002 | USD 7.78002 |
| 2025-11-17 (Monday) | 18,820 | USD 146,420 | USD 146,420 | 0 | USD -4,705 | USD 7.78002 | USD 8.03002 |
| 2025-11-14 (Friday) | 18,820 | USD 151,125 | USD 151,125 | -176 | USD -843 | USD 8.03002 | USD 8 |
| 2025-11-13 (Thursday) | 18,996 | USD 151,968 | USD 151,968 | 0 | USD -6,839 | USD 8 | USD 8.36002 |
| 2025-11-12 (Wednesday) | 18,996 | USD 158,807 | USD 158,807 | 0 | USD -1,899 | USD 8.36002 | USD 8.45999 |
| 2025-11-11 (Tuesday) | 18,996 | USD 160,706 | USD 160,706 | 0 | USD -5,889 | USD 8.45999 | USD 8.77 |
Share price and value of shares held is calculated on the adjusted close price of each day (row). Changes between days reflect the gain/loss of the portfolio as a result of changes in the adjusted close price and changes in the holdingsShare Trades of DNA by Blackrock for IE00BF4RFH31
Show aggregate share trades of DNA| Date | Action | Quantity | Market High | Market Low | Likely Trade Price | Likely Trade Value (Profit/Loss) | Average Price previous trades |
|---|
| 2025-11-26 | SELL | -45 | 9.320 | 8.631 | 8.700 | USD -391 | 9.42 Profit of 33 on sale |
| 2025-11-26 | SELL | -45 | 9.320 | 8.631 | 8.700 | USD -391 | 9.42 Profit of 33 on sale |
| 2025-11-20 | BUY | 135 | 8.536 | 7.723 | 7.805 | USD 1,054 | 9.44 |
| 2025-11-19 | BUY | 1,320 | 8.060 | 7.630 | 7.673 | USD 10,128 | 9.45 |
| 2025-11-14 | SELL | -176 | 8.270 | 7.670 | 7.730 | USD -1,360 | 9.48 Profit of 307 on sale |
| 2025-10-29 | BUY | 88 | 12.190 | 12.820 | 12.757 | USD 1,123 | 9.41 |
| 2025-10-21 | BUY | 176 | 13.130 | 13.760 | 13.697 | USD 2,411 | 9.28 |
| 2025-10-07 | BUY | 86 | 14.820 | 15.440 | 15.378 | USD 1,323 | 9.21 |
| 2025-08-15 | BUY | 86 | 13.180 | 13.465 | 13.437 | USD 1,156 | 8.96 |
| 2025-07-14 | BUY | 176 | 9.940 | 10.241 | 10.211 | USD 1,797 | 8.83 |
| 2025-06-30 | BUY | 176 | 11.250 | 11.500 | 11.475 | USD 2,020 | 8.71 |
| 2025-06-25 | BUY | 264 | 9.320 | 9.430 | 9.419 | USD 2,487 | 8.70 |
| 2025-06-20 | SELL | -44 | 8.570 | 8.728 | 8.712 | USD -383 | 8.70 Loss of 0 on sale |
| 2025-06-12 | SELL | -352 | 9.290 | 9.650 | 9.614 | USD -3,384 | 8.70 Loss of -323 on sale |
| 2025-06-02 | BUY | 132 | 7.130 | 7.380 | 7.355 | USD 971 | 8.74 |
| 2025-05-28 | BUY | 88 | 7.420 | 7.590 | 7.573 | USD 666 | 8.78 |
| 2025-05-14 | BUY | 44 | 7.830 | 8.345 | 8.294 | USD 365 | 8.88 |
| 2025-05-13 | BUY | 88 | 8.120 | 8.400 | 8.372 | USD 737 | 8.89 |
| 2025-05-07 | BUY | 132 | 7.400 | 7.590 | 7.571 | USD 999 | 8.92 |
| 2025-04-28 | BUY | 44 | 8.020 | 8.400 | 8.362 | USD 368 | 9.03 |
| 2025-04-16 | BUY | 559 | 8.090 | 8.582 | 8.533 | USD 4,770 | 9.13 |
| 2025-04-14 | BUY | 86 | 8.360 | 8.690 | 8.657 | USD 745 | 9.14 |
| 2025-04-08 | SELL | -86 | 5.760 | 6.844 | 6.736 | USD -579 | 9.23 Profit of 214 on sale |
| 2025-04-04 | SELL | -86 | 5.570 | 5.591 | 5.589 | USD -481 | 9.30 Profit of 319 on sale |
| 2025-03-28 | BUY | 430 | 6.120 | 6.580 | 6.534 | USD 2,810 | 9.44 |
| 2025-03-12 | SELL | -86 | 6.650 | 7.340 | 7.271 | USD -625 | 9.79 Profit of 216 on sale |
| 2025-03-04 | SELL | -86 | 8.120 | 8.538 | 8.496 | USD -731 | 9.93 Profit of 123 on sale |
| 2025-02-26 | SELL | -172 | 9.110 | 10.230 | 10.118 | USD -1,740 | 10.01 Loss of -19 on sale |
| 2025-02-13 | BUY | 43 | 13.550 | 13.600 | 13.595 | USD 585 | 9.66 |
| 2025-02-12 | BUY | 172 | 12.320 | 12.350 | 12.347 | USD 2,124 | 9.62 |
| 2025-01-27 | BUY | 43 | 11.820 | 12.348 | 12.295 | USD 529 | 8.72 |
| 2025-01-23 | BUY | 43 | 13.180 | 13.205 | 13.202 | USD 568 | 8.55 |
| 2024-12-09 | BUY | 1,548 | 10.700 | 11.980 | 11.852 | USD 18,347 | 8.25 |
| 2024-12-04 | BUY | 86 | 10.410 | 10.480 | 10.473 | USD 901 | 8.08 |
| 2024-12-03 | BUY | 129 | 9.730 | 9.780 | 9.775 | USD 1,261 | 8.04 |
| 2024-11-19 | BUY | 252 | 6.450 | 6.677 | 6.654 | USD 1,677 | 8.15 |
| 2024-11-18 | BUY | 84 | 6.330 | 6.550 | 6.528 | USD 548 | 8.21 |
| 2024-11-12 | BUY | 168 | 8.390 | 8.780 | 8.741 | USD 1,468 | 8.20 |
| 2024-11-11 | BUY | 42 | 8.760 | 8.990 | 8.967 | USD 377 | 8.18 |
| 2024-11-07 | BUY | 210 | 8.380 | 8.510 | 8.497 | USD 1,784 | 8.14 |
| 2024-11-07 | BUY | 210 | 8.380 | 8.510 | 8.497 | USD 1,784 | 8.14 |
| 2024-10-23 | BUY | 84 | 9.050 | 9.750 | 9.680 | USD 813 | 9.15 |
| 2024-10-23 | BUY | 84 | 9.050 | 9.750 | 9.680 | USD 813 | 9.15 |
Market high and low price is on the date. * (if shown) = market close price used not a projected price. This is used when we do not have market data available to calculate a projection
The likely trade price/value is our estimate on the likely price the trade took place at and is not the actual trade price. The likely LOSS/GAIN is our estimate. Where a profit/loss value is shown in the Likely Trade Value column, this is derived from matching trades between periods eg the most recent previous BUY is matched with the SELL for the same number of shares and the difference between the likely BUY price and likely SELL price is calculated. Where a profit or loss is shown in the Average Price of Previous Trades column, this is dervied using the likely trade price compared to the average of previous trades based on adjusted close
Shorting History of DNA
| Date | Shorted Volume | Short Exempt Volume | Total Shares Traded | % Shorted |
|---|
| 2025-09-19 | 311,343 | 0 | 688,141 | 45.2% |
| 2025-09-18 | 237,085 | 0 | 571,984 | 41.4% |
| 2025-09-17 | 390,999 | 200 | 809,164 | 48.3% |
| 2025-09-16 | 244,293 | 0 | 433,049 | 56.4% |
| 2025-09-15 | 238,688 | 0 | 607,266 | 39.3% |
| 2025-09-12 | 389,687 | 6,454 | 759,537 | 51.3% |
| 2025-09-11 | 560,578 | 6,047 | 1,250,189 | 44.8% |
| 2025-09-10 | 466,657 | 0 | 912,674 | 51.1% |
| 2025-09-09 | 304,200 | 275 | 706,987 | 43.0% |
| 2025-09-08 | 351,353 | 36,519 | 736,113 | 47.7% |
| 2025-09-05 | 566,900 | 32,543 | 1,066,272 | 53.2% |
| 2025-09-04 | 354,008 | 8,557 | 645,686 | 54.8% |
| 2025-09-03 | 512,959 | 97,543 | 941,949 | 54.5% |
| 2025-09-02 | 987,971 | 148,378 | 1,789,856 | 55.2% |
| 2025-08-29 | 671,379 | 0 | 1,348,656 | 49.8% |
| 2025-08-28 | 595,231 | 10 | 1,102,037 | 54.0% |
| 2025-08-27 | 492,629 | 0 | 862,153 | 57.1% |
| 2025-08-26 | 520,624 | 639 | 893,417 | 58.3% |
| 2025-08-25 | 396,179 | 0 | 674,045 | 58.8% |
| 2025-08-22 | 579,363 | 815 | 1,073,713 | 54.0% |
| 2025-08-21 | 337,469 | 100 | 579,229 | 58.3% |
| 2025-08-20 | 379,849 | 51,517 | 759,424 | 50.0% |
| 2025-08-19 | 540,731 | 48,192 | 893,264 | 60.5% |
| 2025-08-18 | 547,409 | 2,234 | 895,377 | 61.1% |
| 2025-08-15 | 373,483 | 90 | 594,502 | 62.8% |
| 2025-08-14 | 363,655 | 667 | 715,129 | 50.9% |
| 2025-08-13 | 562,447 | 16,044 | 1,084,196 | 51.9% |
| 2025-08-12 | 291,645 | 0 | 627,061 | 46.5% |
| 2025-08-11 | 313,552 | 55,570 | 672,614 | 46.6% |
| 2025-08-08 | 442,749 | 40,378 | 963,769 | 45.9% |
| 2025-08-07 | 439,411 | 2,264 | 892,118 | 49.3% |
| 2025-08-06 | 365,826 | 2,846 | 613,804 | 59.6% |
| 2025-08-05 | 583,896 | 6,739 | 1,015,182 | 57.5% |
| 2025-08-04 | 493,558 | 61,417 | 827,603 | 59.6% |
| 2025-08-01 | 345,966 | 30,419 | 582,737 | 59.4% |
| 2025-07-31 | 348,579 | 608 | 624,307 | 55.8% |
| 2025-07-30 | 428,497 | 38,545 | 719,106 | 59.6% |
| 2025-07-29 | 337,980 | 2,726 | 695,113 | 48.6% |
| 2025-07-28 | 270,367 | 42,479 | 496,687 | 54.4% |
| 2025-07-25 | 345,445 | 33,133 | 650,899 | 53.1% |
| 2025-07-24 | 733,126 | 343 | 1,480,197 | 49.5% |
| 2025-07-23 | 435,624 | 516 | 1,213,182 | 35.9% |
| 2025-07-22 | 964,959 | 4,757 | 1,585,120 | 60.9% |
| 2025-07-21 | 773,556 | 753 | 1,215,604 | 63.6% |
| 2025-07-18 | 372,602 | 1,023 | 615,488 | 60.5% |
The data here is derived from FINRA daily shorted trade data. The Daily Short Sale Volume is the total volume of short trades that meet certain criteria on each trade date by 6 PM ET on the trade date. The detail trade data is derived from the monthly shorted trade data which will differ in aggregate. The detail trade data is derived from the transaction level data and includes ALL trades (including exempt) and the aggregation period extends beyond 6pm.
Back to Listing
Note: All information is provided as is without warranty and should be used for indicative purposes only.
You should independently check data before making any investment decision.
This information is derived from third party sources and we cannot guarantee that their data is current, accurate, complete, free from defects etc and we therefore accept no responsibility for how it may be used. We accept no liability.